Kim likely to succeed Park Jae-don

Published: 2011-02-10 06:58:00

Updated: 2011-02-10 06:58:00

Kim Myung-Seob, Chairman of Guju Pharmaceutical Co., is likely to be tapped to succeed Park Jae-don to become the next president of Korea Pharmaceutical Industry Cooperative, a business lobby group for small- and medium-sized pharmaceutical firms, it was learned on Tuesday.

If Park steps down...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK